Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)

NCT02021032 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostate Hyperplasia

Interventions

DEVICE: Prolieve

Sponsor

Medifocus, Inc.